Researchers have found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer. Doxorubicin is a well-known anthracycline drug class used primarily in combination chemotherapy
https://goo.gl/gN8E4p
Friday 12 October 2018
Nanoparticles show promise in treatment for triple-negative breast cancer
Researchers have found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer. Doxorubicin is a well-known anthracycline drug class used primarily in combination chemotherapy
https://goo.gl/gN8E4p
Subscribe to:
Post Comments (Atom)
Nanotechnology Events 2019: Speaker Opportunity Available
Be a #Speaker at the 4th International Conference on Nanomedicine and Nanotechnology (#Nanotechnolog y 2019) to be held on May 20-21,...
-
Kindly #Register for the "4th International Conference on Nanomedicine and Nanotechnology". This year #Nanomedicine 2019 has... -
#Book your #speaker slot now at #Nanomedicine 2018 Gather at #Rome, #Italy during August 20-21, 2018 to #explore your #research Click he... -
The #conference will provide a #forum for #professionals in the #Pharma , #MedTech and #Nano industries to learn about the emer...
No comments:
Post a Comment